Skip to main content
ADHERIS-LogoGrayBlue (1)
  • About Us
  • Solutions
  • Investors
  • Talk to our team

Medication Non-Adherence: A Persistent Global Crisis

Medication non-adherence is a significant healthcare challenge, with far-reaching implications for both patients and the pharmaceutical industry. Globally, it costs the industry an estimated $300 billion annually due to additional medical appointments, emergency department visits, and hospitalizations. In the United States alone, non-adherence contributes to over 125,000 preventable deaths each year.1

false https://www.medadvisorsolutions.com/hubfs/Best%20Practices%20for%20Building%20Advanced%20Medication%20Adherence%20Programs.pdf Download Now
true Best Practices for Building Advanced Medication Adherence Programs

Download Now
Insights

Best Practices for Building Advanced Medication Adherence Programs

  • By Admin
  • Jan 13, 2025

Best Practices for Building Advanced Medication Adherence Programs

X

Tell us about you. Learn more about us.

Medication Non-Adherence: A Persistent Global Crisis

Medication non-adherence is a significant healthcare challenge, with far-reaching implications for both patients and the pharmaceutical industry. Globally, it costs the industry an estimated $300 billion annually due to additional medical appointments, emergency department visits, and hospitalizations. In the United States alone, non-adherence contributes to over 125,000 preventable deaths each year.1

Insights
PREVIOUS POST
image

Can I Have Grapefruit with That? How AI Can Transform Pharmacy Patient Engagement

NEXT POST

Adheris Helps Pharmacists in Australia Deliver More Than 115,000 Clinical Services to Patients through Expanded Scope of Practice Pilots in 2024

image

Related Posts

Boosting Patient Adherence with Omnichannel Engagement for GLP-1s
Case Study

Boosting Patient Adherence with Omnichannel Engagement for GLP-1s

Client: Fortune 500 Life Sciences Manufacturer.

Read More
Powering long-term adherence for a PCSK9 inhibitor with predictive patient support
Case Study

Powering long-term adherence for a PCSK9 inhibitor with predictive patient support

For patients at high risk of cardiovascular events, PCSK9 inhibitors represent a critical...

Read More
Enhancing Patient Adherence for Cholesterol-Lowering Medication with Omnichannel Engagement
Case Study

Enhancing Patient Adherence for Cholesterol-Lowering Medication with Omnichannel Engagement

Client: Fortune 500 Life Sciences Manufacturer.

Read More
Increasing Patient Awareness and Engagement for Infectious Viral Disease Treatment
Case Study

Increasing Patient Awareness and Engagement for Infectious Viral Disease Treatment

Client: Fortune 500 Life Sciences Manufacturer.

Read More
  • Home
  • About Us
  • Solutions
  • Investors
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
Adheris
Iso Certified